| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfdf55849dda2962234b611006d86ba9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a89984cd0ba1d2ebd38980ff55c59c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3165f44a47dd0136becbdf31d531127d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c73f74b238764a36cdbd435494744985 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60749a73df584ea86c68a168970fa2e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a19c768402a1dc6450259ddfa41b94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a824a822a3c7386894ffa8ee3daafce5 |
| publicationDate |
2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012071221-A2 |
| titleOfInvention |
Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron |
| abstract |
Compositions for once-daily administration of ondansetron are described. Compositions include a core, a semi-permeable membrane disposed generally around the core, an orifice in the semi-permeable membrane in fluid communication with the core, and a coating having a first therapeutically effective dose of ondansetron or a pharmaceutically acceptable salt disposed generally around the semi-permeable membrane. The core includes first, second, and third layers. The first layer is in fluid communication with the orifice. The second layer includes a second therapeutically effective dose of ondansetron or a pharmaceutically acceptable salt and is located adjacent to the first layer. The third layer is located adjacent the second layer. Methods for treating obsessive compulsive disorder by administering these compositions are also described. |
| priorityDate |
2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |